Hersteller werden bei den einzelnen Losen zugeordnet.
| Los | Titel | Auftragnehmer | Hersteller | Schaetzwert | Vergabewert |
|---|---|---|---|---|---|
| 1 | Acarbose | — | — | ||
| 2 | Atenolol | — | — | ||
| 3 | Baclofen (TAB) | — | — | ||
| 4 | Bimatoprost (0,1 mg; 0,12 mg) | — | — | ||
| 5 | Bosutinib | — | — | ||
| 6 | Brinzolamid + Brimonidin | — | — | ||
| 7 | Budesonid (SUV) | — | — | ||
| 8 | Buprenorphin (PFT; 7 Tage) | — | — | ||
| 9 | Cetirizin (LSE, SAF, LOE, TRO) | — | — | ||
| 10 | Ciclopirox (CRE, LOE) | — | — | ||
| 11 | Cyproteron + Ethinylestradiol | — | — | ||
| 12 | Ebastin (FTA) | — | — | ||
| 13 | Eisencarboxymaltose (IID) | — | — | ||
| 14 | Fluoxetin (20 mg) | — | — | ||
| 15 | Formoterol (12 µg; HPI) | — | — | ||
| 16 | Formoterol (12 µg; IHP) | — | — | ||
| 17 | Formoterol (12,5 µg: HPI) | — | — | ||
| 18 | Ginkgoblätter Trockenextrakt (FTA) | — | — | ||
| 19 | Hydromorphon (AMP, IIL, ILO) | — | — | ||
| 20 | Isotretinoin | — | — | ||
| 21 | Lactulose (SIR) | — | — | ||
| 22 | Lansoprazol | — | — | ||
| 23 | Loperamid (RX) | — | — | ||
| 24 | Loperamid (OTC) | — | — | ||
| 25 | Loratadin | — | — | ||
| 26 | Memantin (LSE) | — | — | ||
| 27 | Methocarbamol (750 mg) | — | — | ||
| 28 | Methocarbamol (1500 mg) | — | — | ||
| 29 | Methylphenidat (RET; 30 St) | — | — | ||
| 30 | Nilotinib | — | — | ||
| 31 | Propranolol (10 mg) | — | — | ||
| 32 | Ramipril + Amlodipin | — | — | ||
| 33 | Risedronsäure | — | — | ||
| 34 | Sulfasalazin | — | — | ||
| 35 | Tacrolimus (SAL) | — | — | ||
| 36 | Triacylglycerollipase (20.000 PhEur.-E.) | — | — | ||
| 37 | Triacylglycerollipase (25.000 PhEur.-E.) | — | — | ||
| 38 | Triamcinolon acetonid (CRE) | — | — | ||
| 39 | Acetylsalicylsäure (100 mg; OTC) | — | — | ||
| 40 | Aprepitant (HKP) | — | — | ||
| 41 | Atomoxetin (HKP) | — | — | ||
| 42 | Bimatoprost (0,3 mg) | — | — | ||
| 43 | Bosentan | — | — | ||
| 44 | Brimonidin (ATR, EDP) | — | — | ||
| 45 | Buprenorphin (PFT; 4 Tage) | — | — | ||
| 46 | Buprenorphin (0,4 mg, 2 mg, 8 mg; SUT) | — | — | ||
| 47 | Cetirizin (FTA) | — | — | ||
| 48 | Dasatinib | — | — | ||
| 49 | Dimethylfumarat | — | — | ||
| 50 | Emtricitabin + Tenofovir disoproxil | — | — | ||
| 51 | Enalapril + Lercanidipin | — | — | ||
| 52 | Entecavir | — | — | ||
| 53 | Etoricoxib | — | — | ||
| 54 | Exemestan | — | — | ||
| 55 | Febuxostat | — | — | ||
| 56 | Flecainid | — | — | ||
| 57 | Hydromorphon (REK, RET) | — | — | ||
| 58 | Hydromorphon (HKP) | — | — | ||
| 59 | Irbesartan + Hydrochlorothiazid | — | — | ||
| 60 | Letrozol | — | — | ||
| 61 | Levetiracetam (FTA) | — | — | ||
| 62 | Levetiracetam (IFK) | — | — | ||
| 63 | Levocetirizin (OTC) | — | — | ||
| 64 | Mometason furoat (NAS, NDS) | — | — | ||
| 65 | Olanzapin (FTA, SMT, TAB, UTA) | — | — | ||
| 66 | Pirfenidon (FTA) | — | — | ||
| 67 | Pomalidomid | — | — | ||
| 68 | Rasagilin | — | — | ||
| 69 | Rivaroxaban | — | — | ||
| 70 | Solifenacin | — | — | ||
| 71 | Tenofovir disoproxil | — | — | ||
| 72 | Testosteron (1000 mg; ILO) | — | — | ||
| 73 | Travoprost | — | — | ||
| 74 | Valsartan | — | — | ||
| 75 | Valsartan + Hydrochlorothiazid | — | — |
Anmelden, um Notizen zu dieser Ausschreibung hinzuzufuegen.